[go: up one dir, main page]

WO2002031127A3 - Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2? - Google Patents

Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2? Download PDF

Info

Publication number
WO2002031127A3
WO2002031127A3 PCT/IB2001/002573 IB0102573W WO0231127A3 WO 2002031127 A3 WO2002031127 A3 WO 2002031127A3 IB 0102573 W IB0102573 W IB 0102573W WO 0231127 A3 WO0231127 A3 WO 0231127A3
Authority
WO
WIPO (PCT)
Prior art keywords
group xii
cloning
recombinant expression
phospholipase
secreted phospholipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/002573
Other languages
French (fr)
Other versions
WO2002031127A2 (en
Inventor
Michel Lazdunski
Gerard Lambeau
Emmanuel Valentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to AU2002222378A priority Critical patent/AU2002222378A1/en
Publication of WO2002031127A2 publication Critical patent/WO2002031127A2/en
Publication of WO2002031127A3 publication Critical patent/WO2002031127A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention conserns DNA and peptide sequances encoding a novel mammalian secreted group XII phospholipase A2 wherein said enzyme contains a potential Ca2+ binding segment GCGSP and more particularly, a novel human group XII phospholipase A¿2?. The invention also conserns the use of this enzyme in methods for screening various chemical compounds
PCT/IB2001/002573 2000-10-11 2001-10-11 Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2? Ceased WO2002031127A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002222378A AU2002222378A1 (en) 2000-10-11 2001-10-11 Cloning and recombinant expression of mammalian group xii secreted phospholipase a2

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23948900P 2000-10-11 2000-10-11
US60/239,489 2000-10-11
US09/975,374 US20020119139A1 (en) 2000-10-11 2001-10-10 Cloning and recombinant expression of mammalian group XII secreted phospholipase A2
US09/975,374 2001-10-10

Publications (2)

Publication Number Publication Date
WO2002031127A2 WO2002031127A2 (en) 2002-04-18
WO2002031127A3 true WO2002031127A3 (en) 2002-10-31

Family

ID=26932614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/002573 Ceased WO2002031127A2 (en) 2000-10-11 2001-10-11 Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2?

Country Status (3)

Country Link
US (1) US20020119139A1 (en)
AU (1) AU2002222378A1 (en)
WO (1) WO2002031127A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040655A2 (en) * 2000-11-06 2002-05-23 President And Fellows Of Harvard College Phospholipase a2 group preferentially expressed in th2 cells
DE10355838A1 (en) * 2003-11-26 2005-07-07 Martin-Luther-Universität Halle-Wittenberg Process for the preparation of phospholipase A2
CA2756997A1 (en) * 2009-03-24 2010-09-30 Universite Joseph Fourier Fertilization modulation compounds and process for implementing them
US8349577B2 (en) * 2009-04-23 2013-01-08 Research Foundation For Mental Hygiene, Inc. Method for evaluating blood-neural barrier permeability

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000610A2 (en) * 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
WO2000004140A1 (en) * 1998-07-15 2000-01-27 Human Genome Sciences, Inc. 71 human secreted proteins
WO2000018904A2 (en) * 1998-09-30 2000-04-06 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
EP1067182A2 (en) * 1999-07-08 2001-01-10 Helix Research Institute Secretory protein or membrane protein
WO2001040466A2 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000610A2 (en) * 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
WO2000004140A1 (en) * 1998-07-15 2000-01-27 Human Genome Sciences, Inc. 71 human secreted proteins
WO2000018904A2 (en) * 1998-09-30 2000-04-06 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
EP1067182A2 (en) * 1999-07-08 2001-01-10 Helix Research Institute Secretory protein or membrane protein
WO2001040466A2 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BEZZINE SOFIANE ET AL: "Exogenously added human group X secreted phospholipase A2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 5, 4 February 2000 (2000-02-04), pages 3179 - 3191, XP002208218, ISSN: 0021-9258 *
CUPILLARD L ET AL: "CLONING CHROMOSOMAL MAPPING, AND EXPRESSION OF A NOVEL HUMAN SECRETORY PHOSPHOLIPASE A2", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 25, 20 June 1997 (1997-06-20), pages 15745 - 15752, XP002936702, ISSN: 0021-9258 *
DENNIS E A: "DIVERSITY OF GROUP TYPES, REGULATION, AND FUNCTION OF PHOSPHOLIPASEA2", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 269, no. 18, 6 May 1994 (1994-05-06), pages 13057 - 13060, XP002923605, ISSN: 0021-9258 *
FENARD DAVID ET AL: "Secreted phospholipases A2, a new class of HIV inhibitors that block virus entry into host cells", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 104, no. 5, September 1999 (1999-09-01), pages 611 - 618, XP002178980, ISSN: 0021-9738 *
GELB MICHAEL H ET AL: "Cloning and recombinant expression of a structurally novel human secreted phospholipase A2.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 51, 22 December 2000 (2000-12-22), pages 39823 - 39826, XP002208219, ISSN: 0021-9258 *
VALENTIN EMMANUEL ET AL: "Novel human secreted phospholipase A2 with homology to the group III bee venom enzyme", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC.,, US, vol. 275, no. 11, 17 March 2000 (2000-03-17), pages 7492 - 7496, XP002178981, ISSN: 0021-9258 *
VALENTIN EMMANUEL ET AL: "On the diversity of secreted phospholipases A2: Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 44, 29 October 1999 (1999-10-29), pages 31195 - 31202, XP002197141, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
US20020119139A1 (en) 2002-08-29
AU2002222378A1 (en) 2002-04-22
WO2002031127A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
ATE460429T1 (en) POLYPEPTIDES CONTAINING EXTRACELLULAR DOMAIN OF IL-20RA AND/OR IL-20RB
WO1997040162A3 (en) Pesticidal toxins
WO2003012105A3 (en) Vegf isoform
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
ATE389666T1 (en) HIGH EXPRESSION RATE OF PROTEINS
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
CA2365697A1 (en) Improved methods for recombinant peptide production
WO1999025843A3 (en) Human checkpoint kinase, hcds1, compositions and methods
WO2004043403A3 (en) Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
DE69534471D1 (en) PEPTIDES THAT ARE CAPABLE OF BINDING THE SH3 DOMAIN OF THE GAP PROTEIN, THEIR ENCODING DNA, THEIR PREPARATION AND USE
WO2002031127A3 (en) Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2?
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
IL139604A (en) Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
AUPP627498A0 (en) Novel peptides - i
ATE550345T1 (en) SFRP, SFRP-INTERACTING PEPTIDE MOTIVES AND METHODS OF USE
AU1183200A (en) Novel gene encoding brain-specific membrane protein
AU2001235894A1 (en) Novel mammalian secreted group iii phospholipase a2
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
WO2000029564A3 (en) Human glycine transporter type 2
WO1999065450A3 (en) Immunosuppressive agents that inhibit calcineurin function and uses thereof
WO2002088168A3 (en) Codon-optimised nucleic acid coding for apoaequorin and uses thereof
AU9362801A (en) A novel polypeptide, a human protein 10 containing a group and the polynucleotide encoding the polypeptide
AU7043301A (en) A novel polypeptide, a human protein 9 containing a fragment of p5cr specific sequence

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP